As we have reported previously, vision loss due to Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) lawsuits involving Ozempic and Mounjaro are being filed. These NAION lawsuits seek legal compensation for the person suffering from this serious eye side effect injury. Ozempic NAION lawsuits … More
Main Navigation Menu
➤ About the Law Offices of Thomas J. Lamb
PRACTICE AREAS
➤ Asbestos and Mesothelioma Claims
➤ Benzene Cancer and Disease Claims
➤ Pharmaceutical Drug Injury Lawsuits
➤ Breast Implants Lymphoma Cancer Lawsuits
➤ Free Case Evaluation by Lawyer Tom Lamb
INFORMATION
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Our "Recent Articles" Archives
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent Articles
Pleural Mesothelioma Diagnosis for the Pulmonologist: Steps Along the Way
Background/Objectives: Malignant pleural mesothelioma (MPM) is a rare, aggressive tumor with a poor prognosis and complex diagnostic pathways. Pulmonologists often play a central role in its initial recognition and investigation. This narrative review synthesizes the current evidence on … More
Andexxa Risks Outweigh Its Benefits, Says FDA In December 2025
When AstraZeneca asserted that their recent Andexxa drug recall had to do with “commercial reasons”, we suggested that there was an Andexxa drug safety issue involved, also, in our December 15, 2025, Drug Injury Watch post, "Andexxa Drug Recall December 2025 Due In Part To Safety Issue That Involves … More
Global burden of lung cancer attributable to occupational asbestos exposure: 1990 to 2021
Background: Asbestos is a well-established occupational carcinogen, with strong evidence linking its exposure to lung cancer. Despite increasing awareness of its health risks, asbestos continues to be used in many countries. We aimed to evaluate the global burden of lung cancer attributable to … More
Wegovy and Ozempic Eye Damage Compensation In Europe, Is US Next?
Drug injury lawsuits seeking compensation for patients with Wegovy and Ozempic eye damage side effects have been filed against the pharmaceutical company Novo Nordisk. These Wegovy and Ozempic eye damage lawsuits have received a boost, it seems, from some recent news out of Europe. From this … More
Depo-Provera: Two Risk Factors for Meningioma Identified in 2025
A new 2025 medical study about Depo-Provera (depot medroxyprogesterone acetate) identified two risk factors for meningioma, a side effect associated with Depo-Provera injections. An article in the November 2025 edition of the medical journal JAMA Neurology, “Depot Medroxyprogesterone Acetate and … More